Nusinersen in Infants who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy: Interim Results from the Phase 2 NURTURE Study

被引：0
|
作者：
Butterfield, R.
De Vivo, D.
Bertini, E.
Hwu, W-L
Crawford, T.
Swoboda, K.
Finkel, R.
Kirschner, J.
Kuntz, N.
Parsons, J.
Ryan, M.
Topaloglu, H.
Ben Omran, T.
Sansone, V
Jong, Y-J
Shu, F.
Johnson, K.
Foster, R.
Bhan, I
Fradette, S.
Farwell, W.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Neuromuscular Disorders; Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
165
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy: interim results from the phase 2 NURTURE study
    Ryan, M.
    De Vivo, D.
    Bertini, E.
    Hwu, W.
    Crawford, T.
    Swoboda, K.
    Finkel, R.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Butterfield, R.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V.
    Jong, Y.
    Shu, F.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 : S185 - S185
  • [2] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Results From the Phase 2 NURTURE Study
    Finkel, Richard S.
    De Vivo, Darryl C.
    Swoboda, Kathryn J.
    Bertini, Enrico
    Hwu, Wuh-Liang
    Foster, Richard
    Bhan, Ishir
    Fradette, Stephanie
    Farwell, Wildon
    [J]. NEUROLOGY, 2020, 94 (15)
  • [3] Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy (SMA): Interim results from the phase 2 nurture study
    Ryan, M. M.
    De Vivo, D. C.
    Bertini, E.
    Hwu, W. L.
    Crawford, T. O.
    Swoboda, K. J.
    Finkel, R. S.
    Kirschner, J.
    Kuntz, N. L.
    Parsons, J.
    Butterfield, R. J.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V. A.
    Jong, Y. J.
    Shu, F.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [4] Nusinersen in infants who initiate treatment in a presymptomatic stage of Spinal Muscular Atrophy (SMA): interim results from the phase 2 NURTURE study
    Sansone, V. A.
    De Vivo, D. C.
    Bertini, E.
    Hwu, W. -L.
    Crawford, T. O.
    Swoboda, K. J.
    Finkel, R. S.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Ryan, M. M.
    Butterfield, R. J.
    Topaloglu, H.
    Ben Omran, T.
    Jong, Y. -J.
    Shu, F.
    Bevernage, S. P.
    Johnson, K.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 83 - 83
  • [5] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Efficacy and Safety Results From the Phase 2 NURTURE Study
    Crawford, T.
    De Vivo, D.
    Bertini, E.
    Hwu, W. L.
    Foster, R.
    Bhan, I
    Farwell, W.
    Reyna, S.
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S392 - S392
  • [6] Nusinersen in Infants Who Initiatte Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Efficacy and Safety Results From the Phase 2 NURTURE Study
    De Vivo, Darryl C.
    Topaloglu, Haluk
    Swoboda, Kathryn J.
    Bertini, Enrico
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Foster, Richard
    Bhan, Ishir
    Fradette, Stephanie
    Farwell, Wildon
    Reyna, Sandra P.
    [J]. NEUROLOGY, 2019, 92 (15)
  • [7] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
    De Vivo, Darryl C.
    Bertini, Enrico
    Swoboda, Kathryn J.
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Finkel, Richard S.
    Kirschner, Janbernd
    Kuntz, Nancy L.
    Parsons, Julie A.
    Ryan, Monique M.
    Butterfield, Russell J.
    Topaloglu, Haluk
    Ben-Omran, Tawfeg
    Sansone, Valeria A.
    Jong, Yuh-Jyh
    Shu, Francy
    Staropoli, John F.
    Kerr, Douglas
    Sandrock, Alfred W.
    Stebbins, Christopher
    Petrillo, Marco
    Braley, Gabriel
    Johnson, Kristina
    Foster, Richard
    Gheuens, Sarah
    Bhan, Ishir
    Reyna, Sandra P.
    Fradette, Stephanie
    Farwell, Wildon
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 (11) : 842 - 856
  • [8] Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy
    De Vivo, Darryl C.
    Hwu, Wuh-Liang
    Reyna, Sandra P.
    Farwell, Wildon
    Gheuens, Sarah
    Sun, Peng
    Zhong, Zhenshao John
    Su, John
    Schneider, Eugene
    Bertini, Enrico
    [J]. NEUROLOGY, 2017, 88
  • [9] Nusinersen effect in infants who initiate treatment in a presymptomatic stage of SMA: NURTURE results
    Crawford, T.
    Ryan, M.
    Kirschner, J.
    Finkel, R.
    Swoboda, K.
    De Vivo, D.
    Bertini, E.
    Hwu, W.
    Foster, R.
    Ramirez-Schrempp, D.
    Chin, R.
    Farwell, W.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 : S125 - S125
  • [10] One-year Outcomes Following Treatment with Nusinersen: Interim Results from the NURTURE Study of Presymptomatic Infants with Genetically Diagnosed Spinal Muscular Atrophy (SMA)
    De Vivo, D.
    Bertini, E.
    Hwu, W-L
    Foster, R.
    Gheuens, S.
    Farwell, W.
    Reyna, S.
    [J]. ANNALS OF NEUROLOGY, 2017, 82 : S265 - S266
12345